Clinical Trial Update: The IMmunotherapy Pleural 5-ALA PDT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 5-ALA photodynamic therapy for malignant pleural mesothelioma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• 5-ALA (5-aminolevulinic acid) for photodynamic therapy (5-aminolevulinic acid)

Snippet

Sponsor: University Hospital, Lille | Conditions: Mesotheliomas Pleural, Malignant Pleural Mesothelioma | Phase 2 | Status: RECRUITING